OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
124.8%
This Fund
S&P 500
1 Year Est. Return
+124.8%
AUM
$758M
AUM Growth
+$493K
(+0.07%)
Holding
62
Top Buys
| 1 | +$23.3M | |
| 2 | +$15.3M | |
| 3 | +$14.7M | |
| 4 |
MeiraGTx Holdings
MGTX
|
+$13.2M |
| 5 |
Q32 Bio
QTTB
|
+$4.95M |
Top Sells
| 1 | +$47.2M | |
| 2 | +$20.1M | |
| 3 | +$17.9M | |
| 4 |
Alkermes
ALKS
|
+$13.7M |
| 5 |
Ocular Therapeutix
OCUL
|
+$9.48M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Harrow
HROW
$1.32B
| $99.9M | 13.17% |
2,832,230
-1,072,770
|
|
||
2
Liquidia Corp
LQDA
$5.52B
| $88.8M | 11.71% |
2,545,000
+110,000
|
|
||
3
Eton Pharmaceutcials
ETON
$873M
| $70.6M | 9.31% |
2,860,000
|
|
||
4
Sol-Gel Technologies
SLGL
$244M
| $39.6M | 5.22% |
500,000
+46,261
|
|
||
5
Rhythm Pharmaceuticals
RYTM
$6.37B
| $35.3M | 4.66% |
123,000
-207,000
|
|
||
6
Apogee Therapeutics
APGE
$5.87B
| $32.8M | 4.33% |
390,000
+1,743
|
|
||
7
Disc Medicine
IRON
$2.7B
| $26.9M | 3.55% |
421,000
+221,000
|
|
||
8
UroGen Pharma
URGN
$1.4B
| $25.7M | 3.39% |
1,430,000
+1,161,577
|
|
||
|
CBIO
9
Crescent Biopharma
CBIO
$592M
| $24.1M | 3.18% |
1,312,615
+134,315
|
|
||
10
Stoke Therapeutics
STOK
$1.97B
| $22.8M | 3.01% |
700,000
+5,000
|
|
||
11
Perspective Therapeutics
CATX
$462M
| $19.5M | 2.57% |
4,675,000
+3,490,500
|
|
||
12
Rezolute
RZLT
$315M
| $19.2M | 2.53% |
6,300,000
+12,844
|
|
||
|
13
MeiraGTx Holdings
MGTX
$926M
| $18.4M | 2.42% |
2,123,259
+1,732,415
|
|
||
14
TG Therapeutics
TGTX
$5.94B
| $17.8M | 2.34% |
535,000
|
|
||
|
SNWV
15
SANUWAVE Health Inc
SNWV
$143M
| $17M | 2.24% |
981,267
|
|
||
16
Edgewise Therapeutics
EWTX
$3.58B
| $15.8M | 2.08% |
500,000
|
|
||
|
ACOG
17
Alpha Cognition
ACOG
$129M
| $14.1M | 1.85% |
2,561,950
+491,166
|
|
||
18
Annexon
ANNX
$880M
| $12.9M | 1.7% |
2,331,761
-268,239
|
|
||
|
ALMS
19
Alumis Inc
ALMS
$2.73B
| $12.1M | 1.6% |
550,000
+15,000
|
|
||
20
Codexis
CDXS
$250M
| $11.1M | 1.46% |
6,785,000
-4,738
|
|
||
21
Protagonist Therapeutics
PTGX
$6.46B
| $10.5M | 1.39% |
100,000
-5,000
|
|
||
22
Revolution Medicines
RVMD
$32.9B
| $9.72M | 1.28% |
100,000
|
|
||
23
Xoma
XOMA
$523M
| $9.41M | 1.24% |
300,000
+7,410
|
|
||
|
24
Q32 Bio
QTTB
$175M
| $8.06M | 1.06% |
1,256,228
+1,042,865
|
|
||
|
MBX
25
MBX Biosciences
MBX
$1.52B
| $7.76M | 1.02% |
260,000
|
|